Human Longevity, Inc. (HLI) provides AI-powered executive health assessments that combine whole genome sequencing, full-body MRI, over 120 biomarkers, and advanced analytics to detect disease risks years before symptoms appear. The company builds and applies the world's largest database of whole genome, phenotype, and clinical data using machine learning to generate personalized health insights and advance precision prevention of aging-related conditions including cancer, cardiovascular disease, metabolic disorders, and neurodegeneration. Founded in 2013 by J. Craig Venter, it operates its flagship programs from South San Francisco, California, and has served more than 10,000 clients.